10 Healthcare Stocks with Highest Dividends

Page 4 of 4

6. Merck & Co., Inc. (NYSE:MRK)

Dividend Yield as of April 15: 2.88%

On April 13, UBS analyst Michael Yee lifted the firm’s price recommendation on Merck & Co., Inc. (NYSE:MRK) to $145 from $130. It reiterated a Buy rating on the shares. The revision was part of a broader Q1 preview across the pharmaceuticals and biotechnology group.

A few days earlier, on April 7, the company said it would begin a cash tender offer, through a subsidiary, to acquire all outstanding shares of common stock of Terns Pharmaceuticals. This followed an earlier move on March 25, 2026, when Merck entered into a definitive agreement to acquire Terns.

If the offer closes as expected, Terns stockholders will receive $53.00 net in cash for each share that is validly tendered and not withdrawn. The payment will not include interest and will be subject to any applicable tax withholding. After the shares are purchased through the tender offer, Terns will become a wholly owned subsidiary of Merck.

Merck & Co., Inc. (NYSE:MRK) is a global healthcare company focused on delivering health solutions through its prescription medicines. Its portfolio includes biologic therapies, vaccines, and animal health products. The Pharmaceutical segment covers its human health pharmaceutical and vaccine business.

While we acknowledge the potential of MRK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MRK and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the 5 Healthcare Stocks with Highest Dividends

Disclosure: None. Follow Insider Monkey on Google News.

Page 4 of 4